FDC has informed that pursuant to the approval of the Hon’ble High Court of Judicature at Bombay on September 04, 2015, approving the Scheme of Amalgamation, the Board of Directors of the Company at its meeting held on September 24, 2015 has allotted 55,385,000 equity shares of face value of Re 1 each to the shareholders of the Transferor Companies i.e. Soven Trading and Investment Company Private Limited, Sudipta Trading and Investment Company Private Limited, Transgene Trading and Investment Company Private Limited, as per the record date of these companies taken as September 22, 2015. Further, pursuant to the High Court Order the Board has cancelled 55,385,000 equity shares of face value Re 1 each held by Soven Trading and Investments Private Limited, Sudipta Trading and Investments Private Limited and Transgene Trading and Investment Company Private Limited.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: